Brofaromine: Unlocking the Future of MAOI Therapy
Brofaromine (Consonar) and Reversible Monoamine Oxidase Inhibition The Core Definition of Brofaromine The compound known by the brand name CONSONAR is chemically identified as Brofaromine, an experimental pharmaceutical agent that falls squarely within the class of psychoactive drugs known as monoamine oxidase inhibitors (MAOIs). Specifically, Brofaromine is categorized as a Reversible Inhibitor of Monoamine Oxidase-A […]
Brofaromine: Unlocking Mood and Neural Balance
Brofaromine: A Comprehensive Encyclopedia Entry The Core Definition of Brofaromine Brofaromine is a novel psychotropic compound identified as a non-selective monoamine reuptake inhibitor, primarily targeting the transporters responsible for the reuptake of serotonin (5-HT) and norepinephrine (NE) in the brain. In essence, it acts by increasing the availability of these crucial neurotransmitters in the synaptic […]